The averages you see in headlines reflect long-term results at higher dosesalongside lifestyle changesnot instant shifts in the first few weeks
At the same time, some evidence suggests that certain GLP-1 drugsespecially semaglutidemay be associated with temporary worsening of diabetic retinopathy in patients who already have retinal disease, particularly when glucose improves quickly
Brain angiotensin enhances dopaminergic cell death via microglial activation and NADPH-derived ROS
Jastreboff, MD, PhD, Professor of Medicine at Yale University School of Medicine and Director of the Y-Weight Obesity Research Center, will discuss the pivotal Phase 3 TRIUMPH-1 trial evaluating the safety and efficacy of retatrutide in people with obesity
Identifying these patterns is essential, because they help determine whether a patient needs a medication that primarily reduces hunger, one that targets cravings and impulsivity, or one that addresses metabolic instability